Evolent Health, Inc. (EVH)
USD 10.71
(-1.47%)
USD 10.71
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.96 Billion | 1.35 Billion | 907.95 Million | 1.02 Billion | 846.38 Million | 627.06 Million |
| Cost of Revenue | 1.5 Billion | 1.03 Billion | 657.55 Million | 701.37 Million | 513.05 Million | 327.82 Million |
| Gross Profit | 460.47 Million | 316.58 Million | 250.4 Million | 321.06 Million | 333.32 Million | 299.23 Million |
| Operating Expenses | 531.68 Million | 336.46 Million | 279.53 Million | 372.02 Million | 453.73 Million | 350.82 Million |
| Selling, General and Administrative Expenses | 358.11 Million | 269.26 Million | 219.49 Million | 310.55 Million | 392.82 Million | 306.3 Million |
| Research and Development Expenses | - | 27 Million | 15.5 Million | 15.1 Million | 19.8 Million | 18.2 Million |
| Other Expenses | 173.57 Million | 67.19 Million | 60.03 Million | 61.47 Million | 60.91 Million | 109 Thousand |
| Cost and Expenses | 2.03 Billion | 1.37 Billion | 937.08 Million | 1.07 Billion | 966.79 Million | 678.64 Million |
| Operating Income | -71.21 Million | -59.83 Million | 30.24 Million | -37.88 Million | -120.4 Million | -47.48 Million |
| Interest Expense | 54.2 Million | 15.57 Million | 25.42 Million | 28.33 Million | 14.53 Million | 5.48 Million |
| Income Tax Expense | -89.36 Million | -43.37 Million | 483 Thousand | -3.55 Million | -21.53 Million | 40 Thousand |
| Earnings before Tax | -202.4 Million | -62.07 Million | -29.8 Million | -337.79 Million | -327.11 Million | -54.15 Million |
| Net Income | -113.04 Million | -18.7 Million | -30.28 Million | -334.24 Million | -305.58 Million | -52.65 Million |
| Earnings Per Share Basic | -1.28 | -0.20 | -0.35 | -3.94 | -3.71 | -0.68 |
| Earnings Per Share Diluted | -1.28 | -0.20 | -0.35 | -3.94 | -3.71 | -0.68 |
| Weighted Average Shares Outstanding | 111.25 Million | 93.69 Million | 86.06 Million | 84.92 Million | 82.36 Million | 77.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.25 Million | 93.69 Million | 86.06 Million | 84.92 Million | 82.36 Million | 77.33 Million |
| Gross Margin | 0.23 | 0.23 | 0.28 | 0.31 | 0.39 | 0.48 |
| EBIT Margin | -0.01 | 0.01 | 0.10 | 0.02 | -0.08 | -0.01 |
| Profit Margin | -0.06 | -0.01 | -0.03 | -0.33 | -0.36 | -0.08 |
| EBITDA | -24.78 Million | 43.74 Million | 55.66 Million | -241.38 Million | -245.94 Million | -4.15 Million |
| Earnings Before Tax Margin | -0.04 | -0.04 | 0.03 | -0.04 | -0.14 | -0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 647.14 Million | 639.65 Million | 556.05 Million | 1.96 Billion | 511.01 Million | 469.13 Million |
| Cost of Revenue | 570.47 Million | 565.05 Million | 454.42 Million | 1.5 Billion | 386.58 Million | 351.93 Million |
| Gross Profit | 76.67 Million | 74.6 Million | 101.62 Million | 460.47 Million | 124.43 Million | 117.19 Million |
| Operating Expenses | 67.21 Million | 68.77 Million | 111.03 Million | 481.52 Million | 128.97 Million | 122.52 Million |
| Selling, General and Administrative Expenses | 67.21 Million | 68.77 Million | 81.42 Million | - | 96.56 Million | 90.38 Million |
| Research and Development Expenses | 6.7 Million | 6.3 Million | 6.6 Million | - | 6.6 Million | 6.8 Million |
| Other Expenses | -105 Thousand | -165 Thousand | 3.98 Million | -62.52 Million | -77 Thousand | -26 Thousand |
| Cost and Expenses | 637.68 Million | 633.82 Million | 565.45 Million | 1.98 Billion | 515.55 Million | 474.46 Million |
| Operating Income | 9.45 Million | 5.82 Million | -21.35 Million | -71.21 Million | -17.93 Million | -21.56 Million |
| Interest Expense | 5.99 Million | 5.99 Million | 12.23 Million | 54.2 Million | 14.61 Million | 14.45 Million |
| Income Tax Expense | -238 Thousand | 565 Thousand | -14.65 Million | -89.36 Million | -5.55 Million | -970 Thousand |
| Earnings before Tax | 1.35 Million | -16.71 Million | -48.06 Million | -202.4 Million | -30.87 Million | -35.29 Million |
| Net Income | 1.59 Million | -17.28 Million | -33.41 Million | -113.04 Million | -25.32 Million | -34.32 Million |
| Earnings Per Share Basic | -0.06 | -0.15 | -0.29 | - | -0.23 | -0.31 |
| Earnings Per Share Diluted | -0.06 | -0.15 | -0.29 | - | -0.23 | -0.31 |
| Weighted Average Shares Outstanding | 114.68 Million | 114.14 Million | 113.58 Million | 111.25 Million | 112.28 Million | 111.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 114.68 Million | 114.14 Million | 113.58 Million | 111.25 Million | 112.28 Million | 111.27 Million |
| Gross Margin | 0.12 | 0.12 | 0.18 | 0.23 | 0.24 | 0.25 |
| EBIT Margin | 0.06 | 0.06 | 0.05 | - | 0.06 | 0.06 |
| Profit Margin | 0.00 | -0.03 | -0.06 | -0.06 | -0.05 | -0.07 |
| EBITDA | 40.44 Million | 35.33 Million | 26.73 Million | - | 29.54 Million | 27.54 Million |
| Earnings Before Tax Margin | 0.01 | 0.01 | -0.04 | -0.04 | -0.04 | -0.05 |
BOMDYEING
1931
QPM
LWAY
GVC
TLGRF